Kotra Industries BhdXKLS:0002 84 PEG Ratio is 1.37 as of Jul. 01, 2026, which is 6% above its 10-year median of 1.29. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.34 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 349 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 56.73% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Kotra Industries Bhd's PEG Ratio or its related term are showing as below:
XKLS:0002'
s PEG Ratio Range Over the Past 10 Years
Min: 0.57 Med: 1.29 Max: 3.53
Current: 1.37
During the past 13 years, Kotra Industries Bhd's highest PEG Ratio was 3.53. The lowest was 0.57. And the median was 1.29.
XKLS:0002's PEG Ratio is ranked better than 56.73% of 349
companies
in the Drug Manufacturers industry
Industry Median: 1.69
vs XKLS:0002: 1.37
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Kotra Industries Bhd (XKLS:0002) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Kotra Industries Bhd PEG Ratio Related Terms
Kotra Industries Bhd PEG Ratio Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0002 vs ZTS, UTHR, VTRS: PEG Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Kotra Industries Bhd (XKLS:0002) has a PEG Ratio of 1.37 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Kotra Industries Bhd and its competitors. This is near median its historical median of 1.29. Over the past decade, Kotra Industries Bhd's PEG Ratio has ranged from 0.57 to 3.53. According to the industry distribution chart, Kotra Industries Bhd ranks #151 out of 349 companies in the Drug Manufacturers industry, placing it in the top 43.3%.
Is Kotra Industries Bhd's PEG Ratio too high?
Kotra Industries Bhd's current PEG Ratio of 1.37 is near median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 3.53. The Drug Manufacturers industry median PEG Ratio is 1.69. Kotra Industries Bhd's value of 1.37 is 18.9% below this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #151 out of 349 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #151 out of 349 companies for PEG Ratio. This puts Kotra Industries Bhd in the upper half of its industry. The industry median PEG Ratio is 1.69. Kotra Industries Bhd's value of 1.37 is 18.9% below this benchmark. Historically, Kotra Industries Bhd's own PEG Ratio has ranged from 0.57 to 3.53 over the past decade. While the company's 10-year median is 1.29 vs. the industry median of 1.69, Kotra Industries Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.69, based on 349 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current PEG Ratio of 1.37 is 18.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current PEG Ratio is 1.37, which is near median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.34, compared to a current price of RM3.72 — trading 14.3% below its estimated fair value. The current PEG Ratio is 1.37, which is near median its 10-year median of 1.29 and 18.9% below the Drug Manufacturers industry median of 1.69. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current PEG Ratio is 1.37 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.72 is trading 14.3% below its estimated GF Value™ of RM4.34.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
PEG Ratio: 1.37 (near median its 10-year median of 1.29)
GF Value™: RM4.34 vs. price of RM3.72 (14.3% below fair value)
Industry Position: 18.9% below the Drug Manufacturers median (#151 of 349)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score
Get the complete analysis for XKLS:0002
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
